Drug Trial Radar · NCT06191640
Sinus Disease in Young Children With Cystic Fibrosis
Last checked: Nov 20, 2026Latest source record: Sep 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Apr 12, 2023
Primary completion
Jun 30, 2029
Study completion Jun 30, 2029
Sponsor
- Lead sponsor
- University of California, Los AngelesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Kansas Medical Center; Children's Hospital Medical Center, Cincinnati; University of Iowa; University of Virginia; University of Vermont; University of North Carolina, Chapel Hill; Children's Hospital Colorado
- First posted
- Jan 5, 2024
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- All sexes, from 2 years, up to 8 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, observational study examining the impact of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators on chronic rhinosinusitis (CRS) and olfactory dysfunction (OD) in young children with cystic fibrosis (YCwCF). This study involves two groups: children 2-8 years old, inclusive at initial visit, receiving highly effective modulator therapy (HEMT), and a control group of children 2-8 years old, inclusive at initial visit, not receiving HEMT. Outcomes will include sinus magnetic resonance imaging (MRI) scans, olfactory tests, and quality of life surveys obtained over a two-year period.
Conditions
- Cystic Fibrosis in Children
- Cystic Fibrosis
- Chronic Rhinosinusitis (Diagnosis)
- Olfactory Disorder
- Olfactory Impairment
Interventions
Ivacaftor or elexacaftor/tezacaftor/ivacaftorDrug
HEMT's are prescribed at the discretion of the treating physician and is not dictated by the principal investigator of this study.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in MRI sinus opacificationTime frame: Baseline, 1-year, and 2-year follow-up
- Change in olfactory bulb volumeTime frame: Baseline, 1-year, and 2-year follow-up
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Children's Hospital Colorado
Aurora, Colorado · Recruiting
University of Iowa
Iowa City, Iowa · Recruiting
University of Kansas Medical Center
Kansas City, Kansas · Recruiting
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio · Recruiting
University of Vermont
Colchester, Vermont · Recruiting
University of Virginia
Charlottesville, Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.